COVID-19

New York Health Department Advises ‘Non-White Race’ COVID Patients to be Prioritized for Treatment

Published

1 year ago

January 3, 2022

Photo by Victor J. Blue/Getty Images

As cases of the omicron Covid variant steamroll through New York, the state government has turned saving lives into a matter of race, prioritizing non-white people to receive treatments. New York claims it is some sort of retribution for “longstanding systemic health and social inequities.”

Last week, New York’s Department of Health released a document to providers titled “Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies and Oral Antivirals for the Treatment of COVID-19 During Ties of Resource Limitations Introduction.”

The document lays out a hierarchy of sorts for who gets to receive the limited supplies of monoclonal antibody treatments and oral antiviral pills recently approved by the U.S. Food and Drug Administration under Emergency Use Authorization.

In addition to individuals considered high-risk such as those who are immunocompromised, aged 65 or older, and overweight, the state provides a “note” that any COVID-infected people who are non-white should receive priority for treatment over white people because of “inequities.”

“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19,” New York’s Department of Health states.

“Consider race and ethnicity when assessing individual risk, as longstanding systemic health and social inequities may contribute to an increased risk of getting sick and dying from COVID-19,” the memo adds.

New York’s rhetoric is consistent with Dr. Anthony Fauci who stated that the COVID-19 pandemic exposed “the undeniable effects of racism” in America.

“Now, very few of these comorbidities have racial determinants,” said Fauci, the chief medical adviser to President Joe Biden. “Almost all relate to the social determinants of health dating back to disadvantageous conditions that some people of color find themselves in from birth regarding the availability of an adequate diet, access to health care, and the undeniable effects of racism in our society.”

China

National Institutes of Health renews ‘bat coronavirus’ research funding

Published

2 weeks ago

May 9, 2023

Sara Carter Staff

Have we not learned our lesson? The now infamous National Institutes of Health has renewed a grant to EcoHealth Alliance for research on the “risk of bat coronavirus spillover emergence.” The news is shocking to many due to multiple agencies of the U.S. government supporting the lab leak theory of Covid’s origin.

“Zoonotic coronaviruses (CoVs) represent a significant threat to global health, as demonstrated by the emergence of SARS-CoV, MERS-CoV and SARS-CoV-2,” a press release read. “Bats were identified as the wildlife reservoirs of SARS-CoV by EcoHealth Alliance, and since then, we have published hundreds of novel SARS-related CoV (SARSr-CoV) sequences from wildlife in China and across Southeast Asia.”

In order to “ease” concerns and some objections, the press release noted on-the-ground work under the auspices of this new grant will not be conducted in China. The study is specific to southern China, but the “renewed work will involve collaboration only between EcoHealth Alliance and the Duke-National University of Singapore Medical School.”

All “recombinant virus culture or infection experiments” will also be removed from the research process. The press release assured that the research would not be “gain of function,” which involves extracting viruses from animals and engineering them in a lab to make them more transmissible or dangerous to humans.

The Biden administration has been supportive. National Review reports:

In February, national-security council communications coordinator John Kirby said the Biden administration supports gain-of-function research despite the potential risks as long as that it is pursued in a safe and transparent manner.

“[The president] believes that [the research is] important to help prevent future pandemics, which means he understands that there has to be legitimate scientific research into . . . the potential sources of pandemics so that we understand [them] and so we can prevent them from happening,” Kirby said.

However, let’s not forget:

in February, FBI director Christopher Wray told Fox News that Covid likely escaped from a laboratory in China, issuing the first public opinion of the sort from the agency on the origins of the virus.

“The FBI has for quite some time now assessed that the origins of the pandemic are most likely a potential lab incident in Wuhan,” Wray said. “Here you are talking about a potential leak from a Chinese government-controlled lab.”